FROM THE 8K ON APRIL 4TH: OWC Pharmaceutical Research Corp. ("OWC") is reporting the issuance on April 5, 2017 of the attached press release, announcing that as a result of the promising conclusions reported in its Form 8-K filed on March 20, 2017, the Company has received expressions of scientific and medical interest, world-wide, for its cannabinoid-based topical cream for treating psoriasis. OWCP has expanded the size and scope of its clinical studies and, as previously announced, anticipates that subject to pending regulatory approvals from applicable jurisdictions, the topical cream should be available for use by those who suffer from psoriasis in the near term.
ALSO LETS NOT FORGET 4/20
In addition we have many news outlets covering MJ which is bringing it back into the light.
CANADA LEGALIZING IT NATIONWIDE.
Too many catalysts to cover.
Once we break key resistance tomorrow we could see $2.00 by EOD
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.